Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
APGNW was delisted on the 22nd of August, 2023.
15 hedge funds and large institutions have $797K invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
36% more funds holding
Funds holding: 11 → 15 (+4)
10% less capital invested
Capital invested by funds: $890K → $797K (-$93K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
+$103K |
| 2 |
CAC
Cowen and Company
New York
|
+$42.2K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$8.67K |
| 4 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
+$69 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$69 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$60K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |
| 3 |
Jane Street
New York
|
-$93 |
APGNW Hedge Fund Activity: Q4 2021 in Review
15 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q4 2021, worth a combined $797K — down 10% from $890K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new APGNW positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Kepos Capital, opening a new position worth an estimated $103K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $60K sold.
- 15 institutional investors held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q4 2021, up from 11 in Q3 2021.
- Funds reported $797K of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q4 2021, down 10% quarter-over-quarter.
- 6 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q4 2021 and 1 closed out, a net change of +5 holders.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant buyer in Q4 2021 was Kepos Capital, an estimated $103K added.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant seller in Q4 2021 was Monashee Investment Management, an estimated $60K sold.
Based on aggregated 13F filings for Q4 2021.